ISCHEMIC STROKE

Image

pRESET

ANEURYSM TREATMENT

ACCESS AND DELIVERY

TECHNOLOGIES

Image

HPC

Hydrophilic Polymer Coating

HPC is an aneurysm implant and Flow Diverter coating, which shall reduce the risk of thrombosis on the surface of stents. Due to the thrombogenic surface, platelet function-inhibiting drugs are needed to prevent in-stent thrombosis. The current solution of preventing platelet activation is the Dual Anti-Platelet Therapy (DAPT) consisting of Aspirin and Clopidogrel. HPC reduces the risk of thrombus formation on the implant by initially reducing or preventing the adhesion of platelets when in contact with blood. The whole implant is covered with an invisible coating.


For more information click here.

NEWS

phenox GmbH expands with opening of new UK office

10. February 2021
As part of this strategy and in the light of Brexit, phenox has taken the decision to open a UK entity materialising in its new office south of Birmingham. Despite a challenging year 2020, phenox GmbH is pursuing its strategic plans in strengthening the footprint in key markets across Europe....
Read More

UPCOMING EVENTS

March

17Mar(Mar 17)0:0019(Mar 19)0:00ISC 2021International Stroke Conference Online

April

23Apr(Apr 23)0:0024(Apr 24)0:00GSANIT 2021Grupo Sud-Americano de Neuro-radiología Intervencionista y TerapéuticaBuenos Aires, Argentina

May

10May(May 10)0:0011(May 11)0:00SLICE - NEXT FRONTIERSSLICE - NEXT FRONTIERS - 100% OnlineOnline

September

01Sep0:0003(Sep 3)0:00ESOC 20217th European Stroke ConferenceHelsinki, Finland

OUR TREATMENT SOLUTIONS

ANEURYSM TREATMENT

ISCHEMIC STROKE

ACCESS AND DELIVERY